tradmap

CABA Earnings Cabaletta Bio, Inc.

Reported EPS, revenue and net income by fiscal period (SEC EDGAR) — quarterly and annual. Full financials → Chart & overview → Updated

Annual results

Diluted EPS (annual)
-$2 -$1 $0 2021 2022 2023 2024 2025
EPS
Net income (annual)
-$168M -$84M $0 2018 2019 2020 2021 2022 2023 2024 2025
Net income
Return on equity (annual)
-150% -18% 114% 0% 2018 2019 2020 2021 2022 2023 2024 2025
ROE

Quarterly results

Diluted EPS (quarterly)
-$2 -$1 $0 Q3 '22 Q2 '23 Q1 '24 Q3 '24 Q2 '25 Q1 '26
EPS
Net income (quarterly)
-$51M -$26M $0 Q3 '23 Q1 '24 Q3 '24 Q1 '25 Q3 '25 Q1 '26
Net income
Return on equity (quarterly)
-42% -21% 0% Q3 '23 Q1 '24 Q3 '24 Q1 '25 Q3 '25 Q1 '26
ROE

Reported EPS history

1–23 of 23
Q2 20262026-06-30-0.722026-08-1310-Q
Q1 20262026-03-31-0.392026-05-1410-Q
FY 20252025-12-31-2.102026-03-2310-K
Q3 20252025-09-30-1.752025-11-1010-Q
Q2 20262025-06-30-1.442026-08-1310-Q
Q1 20262025-03-31-0.712026-05-1410-Q
FY 20252024-12-31-2.342026-03-2310-K
Q3 20252024-09-30-1.692025-11-1010-Q
Q2 20252024-06-30-1.072025-08-0710-Q
Q1 20252024-03-31-0.512025-05-1510-Q
FY 20242023-12-31-1.652025-03-3110-K
Q3 20242023-09-30-1.182024-11-1410-Q
Q2 20242023-06-30-0.812024-08-0810-Q
Q1 20242023-03-31-0.452024-05-1510-Q
FY 20232022-12-31-1.812024-03-2110-K
Q3 20232022-09-30-1.292023-11-0910-Q
Q2 20232022-06-30-0.892023-08-1010-Q
Q1 20232022-03-31-0.452023-05-1110-Q
FY 20222021-12-31-1.802023-03-1610-K
Q3 20222021-09-30-1.312022-11-1010-Q
Q2 20222021-06-30-0.862022-08-1110-Q
Q3 20202019-09-30-9.342020-11-1010-Q
Q2 20202019-06-30-7.482020-08-0610-Q

Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Some issuers (e.g. mortgage REITs, banks) don't report a conventional revenue line, so those charts may be omitted. Informational only — not financial advice.